Commercialization and Innovative Drug Access to Hospitals, Clinically Oriented and Innovative Therapies, Stem Cell Therapy, Extracellular Vesicles Therapy, Cell Therapy, Gene Therapy, Rare Disease, Single-Cell Sequencing, Biomarkers, Immune Cell, TCR-T, CAR-NK, CRISPR/CAS9 Gene Editing, iPSC, PCR, High-Throughput Screening, Application Plans, Continuous Production Process, GMP, AAV, (Non-) Viral Vectors etc.

Monoclonal Antibodies, Bispecific Antibodies and Antibody Drug Couplings (ADCs)、New technologies, techniques、Tumor microenvironment, biomarkers、Tumor companion diagnosis and early screening technologies、Tumor intelligent diagnosis and treatment, precision medicine